0000950170-25-010535.txt : 20250129 0000950170-25-010535.hdr.sgml : 20250129 20250129163010 ACCESSION NUMBER: 0000950170-25-010535 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250128 FILED AS OF DATE: 20250129 DATE AS OF CHANGE: 20250129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: D'Onofrio Matthew J CENTRAL INDEX KEY: 0001578770 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36075 FILM NUMBER: 25569749 MAIL ADDRESS: STREET 1: C/O EVOKE PHARMA, INC. STREET 2: 505 LOMAS SANTA FE DRIVE CITY: SOLANA BEACH STATE: CA ZIP: 92075 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evoke Pharma Inc CENTRAL INDEX KEY: 0001403708 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 208447886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 230 CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: 858-345-1494 MAIL ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 230 CITY: SOLANA BEACH STATE: CA ZIP: 92075 4 1 ownership.xml 4 X0508 4 2025-01-28 0001403708 Evoke Pharma Inc EVOK 0001578770 D'Onofrio Matthew J C/O EVOKE PHARMA, INC. 420 STEVENS AVENUE, SUITE 230 SOLANA BEACH CA 92075 true true false false Chief Executive Officer false Stock Option (Right to Buy) 4.45 2025-01-28 4 A false 70000 0 A 2035-01-27 Common Stock 70000 70000 D One-third of the total number of shares subject to the option shall vest on the 12 month anniversary of January 28, 2025, and one-thirty-sixth of the other two-thirds of the total number of shares subject to the options shall vest on each monthly anniversary of the Vesting Commencement Date thereafter, subject to continuous service to the Company on each such vesting date, so that the options shall be fully vested on the third anniversary of the Vesting Commencement Date. /s/ Matthew J. D'Onofrio 2025-01-29